| Patents for C07K 19 - Hybrid peptides (29,428) |
|---|
| 01/03/2013 | WO2012135284A3 Targeted protein silencing using chimeras between antibodies and ubiquitination enzymes |
| 01/03/2013 | US20130005667 Heterologous expression of neisserial proteins |
| 01/03/2013 | US20130005666 Reporter system for high throughput screening of compounds and uses thereof |
| 01/03/2013 | US20130005659 Il-17 binding compounds and medical uses thereof |
| 01/03/2013 | US20130004991 Positive cytomodulines to improve bioreactor productivity |
| 01/03/2013 | US20130004543 Fibronectin: growth factor chimeras |
| 01/03/2013 | US20130004530 Vaccine composition |
| 01/03/2013 | US20130004513 Agents for treating disease |
| 01/03/2013 | US20130004492 Fgfr extracellular domain acidic region muteins |
| 01/03/2013 | US20130004490 Delivery of transthyretin across the blood-brain barrier as a treatment for alzheimer's disease |
| 01/03/2013 | US20130004489 Activin-actriia antagonists and uses for treating multiple myeloma |
| 01/03/2013 | US20130004431 Transport agents for crossing the blood-brain barrier and into brain cancer cells and methods of use thereof |
| 01/03/2013 | US20130004415 Joint-Homing Peptides and Uses Thereof |
| 01/03/2013 | CA2840409A1 Using sortases to install click chemistry handles for protein ligation |
| 01/03/2013 | CA2839938A1 Photoactivatable receptors and their uses |
| 01/03/2013 | CA2839622A1 Wap domain fusion polypeptides and methods of use thereof |
| 01/03/2013 | CA2839619A1 Serpin fusion polypeptides and methods of use thereof |
| 01/03/2013 | CA2839462A1 Inhibitors of t-cell activation |
| 01/02/2013 | EP2479193A9 Homodimer of insulinotropic peptide analogues and method for preparation thereof and use thereof |
| 01/02/2013 | CN1674934B Vaccine compositions containing amyloid beta1-6 antigen arrays |
| 01/02/2013 | CN1454215B Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 01/02/2013 | CN102859363A Immunoassay Standards And Measurement Of Clinical Biomarkers Using Intra-assay Calibration Standards |
| 01/02/2013 | CN102858962A Compositions for increasing polypeptide stability and activity, and related methods |
| 01/02/2013 | CN102858802A Human antigen binding proteins that bind beta-KLOTHO, FGF receptors and complexes thereof |
| 01/02/2013 | CN102851338A Method for preparing homodimer protein mixture by using charge repulsive interaction |
| 01/02/2013 | CN102850458A Novel recombined dual-function fusion protein and its preparation method and application |
| 01/02/2013 | CN101988058B Gene expression composition, PRRS (Porcine Reproductive and Respiratory Syndrome) oral vaccine and preparation methods thereof |
| 01/02/2013 | CN101903406B Bivalent, bispecific antibodies |
| 01/02/2013 | CN101148661B Human papilloma virus 16 type coat protein virus-like particles, preparation method and use thereof |
| 01/01/2013 | US8344113 Diagnostic tumor markers, drug screening for tumorigenesis inhibition, and compositions and methods for treatment of cancer |
| 01/01/2013 | US8344110 Antibodies to thymic stromal lymphopoietin (TSLP) receptor molecules and uses thereof |
| 01/01/2013 | US8343492 Method for blocking binding of CX3C chemokines using CX3C chemokine antibodies |
| 12/27/2012 | WO2012178136A2 Fusion proteins of bacterial luciferase as multicolor luminescent sensors |
| 12/27/2012 | WO2012177868A1 Fusion peptides comprising multi-functional peptidic solubility tags for efficient production, processing and surface applications |
| 12/27/2012 | WO2012177741A1 Pcsk9-binding polypeptides and methods of use |
| 12/27/2012 | WO2012177653A2 Targeting the neuromuscular junction for treatment |
| 12/27/2012 | WO2012176919A1 Method for preparing polymeric protein composed of monomeric protein produced by fusing protein having immunoglobulin fold structure to protein capable of serving as subunit structure |
| 12/27/2012 | WO2012176853A1 Protein comprising truncated form of extracellular domain protein of frizzled 2, and pharmaceutical composition for treating bone diseases which comprises said protein |
| 12/27/2012 | WO2012176158A1 Purification of chimeric protein |
| 12/27/2012 | WO2012129449A3 High level production of recombinant proteins |
| 12/27/2012 | WO2012124998A3 Bio-pin |
| 12/27/2012 | WO2012050919A3 Chimeric spider silk and uses thereof |
| 12/27/2012 | US20120329998 Luminescent gold nanoparticle functionalized by n-(4-aminobutyl)-n-ethylisoluminol, preparation and application thereof |
| 12/27/2012 | US20120329992 Spider silk proteins and methods for producing spider silk proteins |
| 12/27/2012 | US20120329990 B7-related nucleic acids and polypeptides useful for immunomodulation |
| 12/27/2012 | US20120329987 Metal Abstraction Peptide (MAP) Tag and Associated Methods |
| 12/27/2012 | US20120329728 Compositions and methods for modulating gamma-c-cytokine activity |
| 12/27/2012 | US20120329725 Chimeric Peptides for the Regulation of GTPases |
| 12/27/2012 | US20120329723 Biological Agents Active in Central Nervous System |
| 12/27/2012 | US20120329708 Glucagon/glp-1 receptor co-agonists |
| 12/27/2012 | US20120329707 Glucagon/glp-1 receptor co-agonists |
| 12/27/2012 | US20120329176 Indirectly labelled assay conjugates and methods of preparing and using same |
| 12/27/2012 | US20120328642 Botulinum neurotoxin antigenic compositions and methods |
| 12/27/2012 | US20120328640 Methods and compositions for the treatment and prevention of cancer |
| 12/27/2012 | US20120328620 Epidermalgrowth factor receptor mutations |
| 12/27/2012 | US20120328619 Trispecific Therapeutics Against Acute Myeloid Leukaemia |
| 12/27/2012 | US20120328558 Antibody-light fusion products for cancer therapeutics |
| 12/27/2012 | CA2839986A1 Targeting the neuromuscular junction for treatment |
| 12/27/2012 | CA2839917A1 Compositions, methods and uses for alpha-1 antitrypsin fusion molecules |
| 12/27/2012 | CA2839867A1 Glucagon/glp-1 receptor co-agonists |
| 12/27/2012 | CA2837658A1 Pcsk9-binding polypeptides and methods of use |
| 12/26/2012 | EP2536763A1 Activatable constructs |
| 12/26/2012 | EP2250196B1 Engineered constant domain molecule of an antibody |
| 12/26/2012 | CN102839185A Construction method and application technology of rolGLP-HV engineering bacterium |
| 12/26/2012 | CN102839144A Construction method of anti-tuberculosis medicine high-throughput screening model |
| 12/26/2012 | CN102838680A Helicobacter pylori multiple-epitope fusion protein and multiple-epitope vaccine prepared by helicobacter pylori multiple-epitope fusion protein |
| 12/26/2012 | CN102838679A Preparation and application of Her2-neu antigen positive tumor therapeutic vaccine |
| 12/26/2012 | CN102838655A Solid-liquid separation method for Pichia pastoris fermentation broth |
| 12/26/2012 | CN102321650B Method for producing fluorescent antibacterial silks from transgenic silkworms |
| 12/26/2012 | CN101863985B Recombinant human fusion Tat cytoglobulin and application thereof in treating liver cancer |
| 12/26/2012 | CN101735321B Polypeptide composition and application thereof in detecting tuberculosis antibody |
| 12/26/2012 | CN101407541B Modified allosteric type cyclic citrulline polypeptide, and fusion protein, antibody and reagent kit thereof |
| 12/25/2012 | US8338575 IL-7 fusion proteins |
| 12/25/2012 | US8338168 Chimeric glycoproteins and pseudotyped lentiviral vectors |
| 12/20/2012 | WO2012172521A1 Soluble proteins for use as therapeutics |
| 12/20/2012 | WO2012144726A3 Tumor antigen proteins or genes of polo-like kinase 1 |
| 12/20/2012 | WO2012121577A3 Composition for strengthening tissue regenerative power of stem cell having pten |
| 12/20/2012 | US20120324602 Complexes of an3-interacting proteins and their use for plant growth promotion |
| 12/20/2012 | US20120322989 Crystal structures of neuropilin fragments and neuropilin-antibody complexes |
| 12/20/2012 | US20120322979 Method of producing recombinant TAT-HOXB4H protein for use as a stimulant of hematopoiesis in vivo |
| 12/20/2012 | US20120322735 Modified growth hormone polypeptides |
| 12/20/2012 | US20120322156 Membrane fusion proteins derived from reovirus |
| 12/20/2012 | US20120322085 Therapeutic agent for autoimmune diseases or allergy, and method for screening for the therapeutic agent |
| 12/20/2012 | US20120321697 Bpb-based cargo delivery system |
| 12/20/2012 | US20120321659 Hbv core antigen particles with multiple immunogenic components attached via peptide ligands |
| 12/20/2012 | US20120321657 Group a streptococcus multivalent vaccine |
| 12/20/2012 | US20120321653 Novel chimeric polynucleotides and polypeptides enabling the secretion of a polypeptide of interest in combination with exosomes and uses thereof |
| 12/20/2012 | US20120321651 Anti-IGE Vaccines |
| 12/20/2012 | US20120321628 Hepatocyte growth factor receptor antagonists and uses thereof |
| 12/20/2012 | US20120321624 Targeting the neuromuscular junction for treatment |
| 12/20/2012 | US20120321623 ILT3 Polypeptides and Uses Thereof |
| 12/20/2012 | US20120321589 Antibody Fusion Proteins with Disrupted Heparin-Binding Activity |
| 12/20/2012 | CA2838478A1 Soluble proteins for use as therapeutics |
| 12/19/2012 | EP2534490A1 Immunoassay standards and measurement of clinical biomarkers using intra-assay calibration standards |
| 12/19/2012 | EP2534257A2 Methods for identifying and isolating cells expressing a polypeptide |
| 12/19/2012 | CN102834415A Filler for affinity chromatography and method for isolating immunoglobulin |
| 12/19/2012 | CN102834411A Peptides, devices, and methods for the detection of ehrlichia antibodies |
| 12/19/2012 | CN102827292A Fusion protein TgMEP as well as preparation method and application thereof |
| 12/19/2012 | CN102827291A Recombinant fusion protein PTD-HSP27 and use thereof |
| 12/19/2012 | CN102827290A Fusion protein of human serum albumin and lipolysis structural domain of human growth hormone |